Recruiting NA Cleft Lip and Palate

New treatment option for Cleft Lip and Palate

Official title Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate

ClinicalTrials.gov ID: NCT05081258

What this study is testing

What it's testing
Orofacial clefts are the second most common birth deformity and vary in etiology and phenotype, e.g. isolated cleft palate, cleft lip or cleft lip palate.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 1 to 2. Healthy volunteers may be eligible.

You may be able to join if

  • newborns/infants with non-syndromal (ns) unilateral cleft lip palate (UCLP)
  • signed informed consent by the parents or legal guardian

You likely can't join if

  • newborns/infants with syndromal (s) unilateral cleft lip palate (UCLP)
  • insufficient adherence and compliance by the parents or legal guardian
  • withdrawal of informed consent by the parents or legal guardian

The study team makes the final eligibility decision.

Where it's taking place

  • Erlangen, Bavaria, Germany

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 1 day to 2 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Erlangen, Bavaria, Germany. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.